[Reported use of thalidomide in multiple myeloma: presentation of problems in the Thaled® outpatient department].

Background: Thalidomide was approved in Japan for multiple myeloma treatment in October 2008. A program called the Thalidomide Education and Risk Management System (TERMS®) was established to help ensure that every effort is made to use the drug safely.

Purpose: We report the use of thalidomide to treat multiple myeloma, and describe problems arising in the Thaled® outpatient department.